05/11/2026
As a full-service CDMO, Rose Bio offers manufacturing across the full suite of plasmid DNA, viral vector, and cell therapies, as well as cell supply operations.
05/11/2026
The tender offer, launched on April 5, 2026, and expired on April 22, 2026.
05/05/2026
The first acquisition is of a manufacturing facility and business at Eltringham Works in Prudhoe, near Newcastle, previously operated by Horizon Products.
05/05/2026
Atlas was advised by fundraising advisor firm, First Point Equity, and fund administration and appointed representative services provided by Langham Hall.
05/01/2026
The transaction marks a major milestone for Enviromena and strengthens its ability to deliver large-scale solar projects at pace and at scale, supporting the UK’s energy transition and net zero ambitions.